Trial Details
TERMINATEDBasic Information
| Clinical ID | c590 |
|---|---|
| Identifier | NCT03758443 |
| Trial Title | Efficacy & Safety of TD-1473 in Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis (UC) |
| Interventions | DRUG: TD-1473 Dose A|DRUG: TD-1473 Dose B|DRUG: TD-1473 Dose C|DRUG: Placebo |
Participant Information
| Sponsor | Theravance Biopharma |
|---|---|
| City | Chula Vista |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2019-03-11 |
|---|---|
| Primary Completion Date | 2021-10-20 |
| Completion Date | 2021-10-20 |